Log in to save to my catalogue

Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy

Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e22ef2890e54fa88f063d626c591de8

Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy

About this item

Full title

Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy

Publisher

Basel: MDPI AG

Journal title

Pharmaceutics, 2022-10, Vol.14 (10), p.2129

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Gene therapy holds great promise in the treatment of genetic diseases. It is now possible to make DNA modifications using the CRISPR system. However, a major problem remains: the delivery of these CRISPR-derived technologies to specific organs. Lipid nanoparticles (LNPs) have emerged as a very promising delivery method. However, when delivering LNP...

Alternative Titles

Full title

Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9e22ef2890e54fa88f063d626c591de8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e22ef2890e54fa88f063d626c591de8

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics14102129

How to access this item